FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Syncromune®, Inc., a clinical-stage biopharmaceutical ...

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Zydus introduces biosimilar denosumab 120 mg SC – protecting bone health in cancer patients: Our Bureau, Mumbai Wednesday, December 10, 2025, 13:30 Hrs [IST] Zydus Lifesciences ...

In November 2025, Rana McKay, MD initiated a phase 2 study of the combination of cabozantinib + nivolumab in subjects with advanced castration-resistant prostate cancer (CRPC). DelveInsight's Bone ...

Denosumab is a monoclonal antibody with several indications related to bone health, primarily used in the treatment of ...

Patel, Managing Director, Zydus Lifesciences, said With Denosumab 120 mg SC, we aim to bring access, affordability of medication in cancer patients needing critical care. This will help patients to ...

Father of Cancer Genetics, Dr Henry Lynch, Has Died Aged 91 A pioneer in the study of cancer and genetics, Lynch discovered the most common form of hereditary colorectal cancer, now known as Lynch ...